IL-12/IL-13 axis in allergic asthma

Journal of Allergy and Clinical Immunology

Volumn 107, Issue 1, 2001, Pages 9-18

  Wills Karp, Marsha ^a  

^a Children's Hospital Medical Center   (United States)

Author keywords

Allergy; Asthma; Cytokine; T cell differentiation

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 13;

ALLERGIC ASTHMA; BRONCHUS HYPERREACTIVITY; CHROMOSOME 5Q; CYTOKINE PRODUCTION; DISEASE COURSE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; IMMUNE RESPONSE; LUNG FIBROSIS; MUCUS SECRETION; PRIORITY JOURNAL; REVIEW;

EID: 0035141618     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.112265     Document Type: Article

References (68)

1. Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes
2. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations
3. Genetic susceptibility to asthma-bronchial hyperresponsiveness coinherited with a major gene for atopy
4. Developmental commitment to the Th2 lineage by extinction of IL-12 signaling
5. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat 4
6. The interleukin-12 gene promoter is primed by interferon-γ in monocytic cells
7. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses
8. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: Priming for IL-12 and tumor necrosis factor-α production
9. Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production
10. Prostaglandin E2 and dexamethasone inhibit IL-12 receptor expression and IL-12 responsiveness
11. Histamine potently suppresses human IL-12 and stimulates IL-10 production via H2 receptors
12. Natural killer cell stimulatory factor (interleukin-12 [IL-12] induces T helper type 1 (Th)-specific immune responses and inhibits the development of IL-4 producing Th cells
13. Recombinant interleukin-12 suppresses the synthesis of IgE by interleukin-4 stimulated human lymphocytes
14. IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes
15. Resistance to antigen-induced airway hyperresponsiveness requires endogenous production of IL-12
16. IL-12 regulates bone marrow eosinophilia and airway eotaxin levels induced by airway allergen exposure
17. Immunomodulatory effects of IL-12 on allergic lung inflammation depend on timing of doses
18. Interleukin 12 inhibits antigen-induced antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice
19. Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice
20. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type l-dominated immune response and inhibiting antigen-specific IgE production
21. Role of IFN-gamma in the inhibition of the allergic airway inflammation caused by IL-12
22. Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy
23. Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy
24. Reduced production of IL-12 and IL-12-dependent IFN-γ release in patients with allergic asthma
25. Reduced IL-12 level correlates with decreased IFN-γ secreting T cells but not natural killer cell activity in asthmatic children
26. Modulatory effects of alveolar macrophages on CD4+ T-cell IL-5 responses correlate with IL-1beta, IL-6, and IL- 12 production
27. Rare polymorphisms in the promoter regions of the human interleukin-12 p35 and interleukin-12 p40 subunit genes
28. Mutations of the IL-12 receptor beta2 chain gene in atopic subjects
29. Expression of interleukin (IL)-12 (p40) and IL-12 (beta 2) receptors in allergic rhinitis and chronic sinusitis
30. Beta-adrenergic modulation of human type-1/type-2 cytokine balance
31. Glucocorticoids inhibit bioactive IL-12p70 production by in vitro-generated human dendritic cells without affecting their T cell stimulatory potential
32. Corticosteroids inhibit IL- 12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ T lymphocytes
33. Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells
34. Inhibition of Th1 immune response by glucocorticoids: Dexamethasone selectively inhibits IL-12-induced STAT4 phosphorylation in T lymphocytes
35. Effect of fluticasone propionate on interleukin-12 and interferon-gamma production in patients affected by allergic bronchial asthma
36. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not T cells
37. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of interleukin 4 receptor
38. cDNA cloning and characterization of the human interleukin 13 receptor α chain
39. The distribution of IL-13 receptor alpha 1 expression on B cells. T cells and monocytes and its regulation by IL-13 and IL-4
40. The role of IL-13 and its receptor in allergy and inflammatory responses
41. Interleukin-4 is required for the induction of lung Th2 mucosal immunity
42. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity
43. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in Balb/c mice independently of IL-4 and IL-5
44. IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells
45. Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice
46. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production
47. Interleukin-13: Central mediator of allergic asthma
48. Requirement for IL-13 independently of IL-4 in experimental asthma
49. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
50. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity
51. Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: Suppression of IL-13 binding by IL-2 receptor gamma chain
52. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression on airway epithelial cells
53. Interleukin-13 modulates carbachol- and KCL-evoked contractile responses in murine tracheal rings
54. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes
55. Interleukin-13 and interleukin-4 are coexpressed in atopic asthma
56. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma
57. IL-13 expression at the sites of allergen challenge in patients with asthma
58. Association between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression and the infiltration of eosinophils, macrophages and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects
59. Cytokine profiles of BAL T cells and T-cell clones obtained from human asthmatic airways after local allergen challenge
60. Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations
61. Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: Relationship to interleukin-4 and eosinophil counts
62. An IL-13 promoter polymorphism associated with increased risk of allergic asthma
63. Genetic variants of IL-13 signalling and human asthma and atopy
64. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children
65. The association of atopy with a gain-of-function mutation in the α-subunit of the interleukin-4 receptor
66. Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations
67. The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction
68. Cutting edge: Effects of an allergy-associated mutation in the human IL-4Rα (Q576R) on human IL-4-induced signal transduction